Biomedical research at Oslo University Hospital
Oslo University Hospital is a merger of three former university hospitals in Oslo. Biomedical research is one of the hospital's core activities. Research at the hospital is closely interlinked with research undertaken at the University of Oslo. More than 50% of all biomedical research in Norway is published by researchers affiliated with the hospital. Research undertaken cover both basic research, translational research, and clinical research.
Oslo University Hospital has a central role in developing and supporting biomedical research within the South-Eastern Regional Health Authority. The hospital also pursues international research collaborations.
Click here to see hierarchical division and subunit overview
Summary of publications:
Publications (original articles or review articles) published in 2019 from OUS - Addiction Treatment Research Units
17 publications found
Measuring Personality Problems in Patients With Substance Use Disorders: A Cross-Sample Validation
J Dual Diagn, 15 (4), 324-332
DOI 10.1080/15504263.2019.1668583, PubMed 31571533
Mortality and causes of death among patients with opioid use disorder receiving opioid agonist treatment: a national register study
BMC Health Serv Res, 19 (1), 440
DOI 10.1186/s12913-019-4282-z, PubMed 31266495
Predicting Dropout from Inpatient Substance Use Disorder Treatment: A Prospective Validation Study of the OQ-Analyst
Subst Abuse, 13, 1178221819866181
DOI 10.1177/1178221819866181, PubMed 31452601
Anabolic androgenic steroid dependence is associated with impaired emotion recognition
Psychopharmacology (Berl), 236 (9), 2667-2676
DOI 10.1007/s00213-019-05239-7, PubMed 30941469
Structural brain characteristics of anabolic-androgenic steroid dependence in men
Addiction, 114 (8), 1405-1415
DOI 10.1111/add.14629, PubMed 30955206
Anabolic-androgenic steroid users receiving health-related information; health problems, motivations to quit and treatment desires
Subst Abuse Treat Prev Policy, 14 (1), 20
DOI 10.1186/s13011-019-0206-5, PubMed 31096999
Treating Patients With Co-occurring Autism Spectrum Disorder and Substance Use Disorder: A Clinical Explorative Study
Subst Abuse, 13, 1178221819843291
DOI 10.1177/1178221819843291, PubMed 31024216
Anxiety, Depression, and Insomnia Among Adults With Opioid Dependence Treated With Extended-Release Naltrexone vs Buprenorphine-Naloxone: A Randomized Clinical Trial and Follow-up Study
JAMA Psychiatry, 76 (2), 127-134
DOI 10.1001/jamapsychiatry.2018.3537, PubMed 30566177
No increased pain among opioid-dependent individuals treated with extended-release naltrexone or buprenorphine-naloxone: A 3-month randomized study and 9-month open-treatment follow-up study
Am J Addict, 28 (2), 77-85
DOI 10.1111/ajad.12859, PubMed 30701613
Measuring the quality of life of incarcerated individuals
Int J Prison Health, 15 (1), 1-13
DOI 10.1108/IJPH-02-2018-0005, PubMed 30827162
Psychometric Properties of the Severity Indices of Personality Problems (SIPP) in Two Samples A Norwegian Community Sample and Clinical Samples of Patients With and Without Personality Disorders
Eur. J. Psychol. Assess., 35 (5), 698-711
Partnering with persons in long-term recovery from substance use disorder: experiences from a collaborative research project
Harm Reduct J, 16 (1), 40
DOI 10.1186/s12954-019-0310-x, PubMed 31234878
Cannabis use in early adulthood is prospectively associated with prescriptions of antipsychotics, mood stabilizers, and antidepressants
Acta Psychiatr Scand, 141 (2), 149-156
DOI 10.1111/acps.13104, PubMed 31560790
Availability of Extended-Release Naltrexone May Increase the Number of Opioid-Dependent Individuals in Treatment: Extension of a Randomized Clinical Trial
Eur Addict Res, 25 (6), 303-309
DOI 10.1159/000501931, PubMed 31340204
The Montreal Cognitive Assessment as a predictor of dropout from residential substance use disorder treatment
Heliyon, 5 (3), e01282
DOI 10.1016/j.heliyon.2019.e01282, PubMed 31025003
Polydrug Use - prevalence and registration
Tidsskr. Nor. Laegeforen., 139 (13), 1279-1281
Polydrug use - prevalence and registration
Tidsskr Nor Laegeforen, 139 (13)
DOI 10.4045/tidsskr.19.0251, PubMed 31556532